Feasibility and Performance of Elastin Trichrome as a Primary Stain in Colorectal Cancer Resection Specimens: Results of an Interobserver Variability Study.


Journal

The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904

Informations de publication

Date de publication:
01 10 2021
Historique:
pubmed: 24 3 2021
medline: 5 10 2021
entrez: 23 3 2021
Statut: ppublish

Résumé

Venous invasion (VI) is a powerful prognostic factor in colorectal cancer (CRC) that is widely underreported. The ability of elastin stains to improve VI detection is now recognized in several international CRC pathology protocols. However, concerns related to the cost and time required to perform and evaluate these stains in addition to routine hematoxylin and eosin (H&E) stains remains a barrier to their wider use. We therefore sought to determine whether an elastin trichrome (ET) stain could be used as a "stand-alone" stain in CRC resections, by comparing the sensitivity, accuracy, and reproducibility of detection of CAP-mandated prognostic factors using ET and H&E stains. Representative H&E- and ET-stained slides from 50 CRC resections, including a representative mix of stages and prognostic factors, were used to generate 2 study sets. Each case was represented by H&E slides in 1 study set and by corresponding ET slides from the same blocks in the other study set. Ten observers (3 academic gastrointestinal [GI] pathologists, 4 community pathologists, 3 fellows) evaluated each study set for CAP-mandated prognostic factors. ET outperformed H&E in the assessment of VI with respect to detection rates (50% vs. 28.6%; P<0.0001), accuracy (82% vs. 59%, P<0.0001), and reproducibility (k=0.554 vs. 0.394). No significant differences between ET and H&E were observed for other features evaluated. In a poststudy survey, most observers considered the ease and speed of assessment at least equivalent for ET and H&E for most prognostic factors, and felt that ET would be feasible as a stand-alone stain in practice. If validated by others, our findings support the use of ET, rather than H&E, as the primary stain for the evaluation of CRC resections.

Identifiants

pubmed: 33756495
doi: 10.1097/PAS.0000000000001707
pii: 00000478-202110000-00014
doi:

Substances chimiques

Azo Compounds 0
Biomarkers, Tumor 0
Coloring Agents 0
ELN protein, human 0
trichrome stain 0
Methyl Green 82-94-0
Elastin 9007-58-3
Eosine Yellowish-(YS) TDQ283MPCW

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1419-1427

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Références

Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg. 1985;72:698–702.
Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet. 1984;2:733–736.
Harrison JC, Dean PJ, el-Zeky F, et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498–505.
Heys SD, Sherif A, Bagley JS, et al. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81:685–688.
Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum. 1991;34:798–804.
Quirke P, Morris E. Reporting colorectal cancer. Histopathology. 2007;50:103–112.
Sato T, Ueno H, Mochizuki H, et al. Objective criteria for the grading of venous invasion in colorectal cancer. Am J Surg Pathol. 2010;34:454–462.
Chan YM, MacKay C, Ritchie DT, et al. Screen detection is a survival predictor independent of pathological grade in colorectal cancer. A prospective cohort study. Surg J R Coll Surg Edinb Irel. 2021;19:20–26.
Shin Y-M, Pyo J-S, Park MJ. The impact of extramural venous invasion in colorectal cancer: a detailed analysis based on tumor location and evaluation methods. Int J Surg Pathol. 2020;28:120–127.
Betge J, Pollheimer MJ, Lindtner RA, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012;118:628–638.
Roxburgh CSD, McMillan DC, Anderson JH, et al. Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg. 2010;252:989–997.
Cyr D, Akder A, Shivji S, et al. Extramural venous invasion detected with an elastin stain is a powerful predictor of cancer-specific mortality in STAGE I-IIIB resected colorectal cancer. Ann Oncol . 2020;31(suppl 3):S133.
Abdulkader M, Abdulla K, Rakha E, et al. Routine elastic staining assists detection of vascular invasion in colorectal cancer. Histopathology. 2006;49:487–492.
Dirschmid K, Lang A, Mathis G, et al. Incidence of extramural venous invasion in colorectal carcinoma: findings with a new technique. Hum Pathol. 1996;27:1227–1230.
Inoue T, Mori M, Shimono R, et al. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum. 1992;35:34–39.
Hwang C, Lee S, Kim A, et al. Venous invasion in colorectal cancer: impact of morphologic findings on detection rate. Cancer Res Treat. 2016;48:1222–1228.
Kirsch R, Messenger DE, Riddell RH, et al. Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Am J Surg Pathol. 2013;37:200–210.
Messenger DE, Driman DK, Kirsch R. Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol. 2012;43:965–973.
Messenger DE, Driman DK, McLeod RS, et al. Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer. J Clin Pathol. 2011;64:983–989.
The Royal College of Pathologists. Dataset for Colorectal Cancer Histopathology Reports Version 4. The Royal College of Pathologists; 2018. Available at: https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html .
College of American Pathologists. Protocol for the Examination of Resection Specimens From Patients With Primary Carcinoma of the Colon and Rectum Version 4000. College of American Pathologists; 2017. Available at: https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates .
Howlett CJ, Tweedie EJ, Driman DK. Use of an elastic stain to show venous invasion in colorectal carcinoma: a simple technique for detection of an important prognostic factor. J Clin Pathol. 2009;62:1021–1025.
Kingston EF, Goulding H, Bateman AC. Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum. 2007;50:1867–1872.
Vass DG, Ainsworth R, Anderson JH, et al. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol. 2004;57:769–772.
Sternberg A, Amar M, Alfici R, et al. Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J Clin Pathol. 2002;55:17–21.
Sejben I, Bori R, Cserni G. Venous invasion demonstrated by orcein staining of colorectal carcinoma specimens is associated with the development of distant metastasis. J Clin Pathol. 2010;63:575–578.
Van Wyk HC, Foulis AK, Roxburgh CS, et al. Comparison of methods to identify lymphatic and blood vessel invasion and their prognostic value in patients with primary operable colorectal cancer. Anticancer Res. 2015;35:6457–6463.
Smith G, Waddell N, Riley A. The benefits of elastic—no stretch of the imagination. J Clin Pathol. 2006;59:888–889.
Roxburgh CSD, McMillan DC, Richards CH, et al. The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer. Ann Surg. 2014;259:1156–1165.
Loughrey MB, Arends M, Brown I, et al. Colorectal Cancer Histopathology. Reporting Guide (ISBN: 978-1-922324-01-6). Sydney, Australia: International Collaboration on Cancer Reporting. 2020. Available at: http://www.iccr-cancer.org/datasets/published-datasets/digestive-tract/colorectal .
Suzuki A, Togashi K, Nokubi M, et al. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Surg Pathol. 2009;33:1601–1607.
Watanabe T, Muro K, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1–34.
The Royal College of Pathologists of Australasia. Colorectal Cancer Structured Reporting Protocol Version 40. The Royal College of Pathologists; 2020. Available at: https://www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols .
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
Kojima M, Nakajima K, Ishii G, et al. Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol. 2010;34:1351–1360.
Liang W-Y, Chang W-C, Hsu C-Y, et al. Retrospective evaluation of elastic stain in the assessment of serosal invasion of pT3N0 colorectal cancers. Am J Surg Pathol. 2013;37:1565–1570.
Shinto E, Ueno H, Hashiguchi Y, et al. The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum. 2004;47:467–473.
Yokota M, Kojima M, Nomura S, et al. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III. Dis Colon Rectum. 2014;57:830–838.
Nakanishi Y, LeVea C, Dibaj S, et al. Reappraisal of serosal invasion in patients with T3 colorectal cancer by elastic stain: clinicopathologic study of 139 surgical cases with special reference to peritoneal elastic lamina invasion. Arch Pathol Lab Med. 2016;140:81–85.
Ueno H, Shirouzu K, Eishi Y, et al. Characterization of perineural invasion as a component of colorectal cancer staging. Am J Surg Pathol. 2013;37:1542–1549.
Ueno H, Shirouzu K, Shimazaki H, et al. Histogenesis and prognostic value of myenteric spread in colorectal cancer: a Japanese multi-institutional study. J Gastroenterol. 2014;49:400–407.
Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379–3391.
White M, Foulis AK, Smith G, et al. The role of S100 staining in the pathological assessment of perineural invasion in rectal cancer. Colorectal Dis. 2014;16:71–72.

Auteurs

Sameer Shivji (S)

Mount Sinai Hospital.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.

Ipshita Kak (I)

Mount Sinai Hospital.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.

Stephanie L Reid (SL)

Mount Sinai Hospital.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.

Jennifer Muir (J)

Mount Sinai Hospital.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.

Sara Hafezi-Bakhtiari (S)

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.
Lakeridge Health, Oshawa.

Hector Li-Chang (H)

Royal Victoria Regional Health Centre, Barrie.

Ardit Deliallisi (A)

Grey Bruce Health Services, Owen Sound.

Ken J Newell (KJ)

Grey Bruce Health Services, Owen Sound.

Andrea Grin (A)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.

James Conner (J)

Mount Sinai Hospital.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.

Richard Kirsch (R)

Mount Sinai Hospital.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH